Tiago M. De Carvalho

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage.

Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage.

Journal: International journal of cancer

Published: June 20, 2025

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.

Journal: The Lancet. Oncology

Published: June 14, 2022

Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.

Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: June 08, 2021

Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators.

Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: June 11, 2019

Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithms.

Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithms.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 01, 2019

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Journal: Annals of internal medicine

Published: September 05, 2017

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

Journal: Cancer

Published: July 05, 2017

Summary statement on screening for prostate cancer in Europe.

Summary statement on screening for prostate cancer in Europe.

Journal: International journal of cancer

Published: June 15, 2017

Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.

Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.

Journal: Cancer

Published: May 30, 2017

When should active surveillance for prostate cancer stop if no progression is detected?

When should active surveillance for prostate cancer stop if no progression is detected?

Journal: The Prostate

Published: November 08, 2016

Is prostate cancer different in black men? Answers from 3 natural history models.

Is prostate cancer different in black men? Answers from 3 natural history models.

Journal: Cancer

Published: October 04, 2016

Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.

Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.

Journal: BJU international

Published: May 26, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026